| |
| |
|
| Insider
Information: |
Grant Stuart |
| Relationship: |
EVP and CFO |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
57,102 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$255,817 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,102 |
|
|
| Total
Value |
$255,817 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
SR VP & CFO |
2011-03-16 |
57,102 |
2008-08-04 |
0 |
Premium* |
|
|
Patheon NV |
PTHN |
EVP and CFO |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTHN |
Patheon NV |
EVP and CFO |
• – – |
2017-08-29 |
4 |
D |
$35.00 |
$19,831,105 |
I/I |
(566,603) |
0 |
0 |
- |
|
| PTHN |
Patheon NV |
EVP and CFO |
• – – |
2017-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(196,485) |
0 |
0 |
- |
|
| PTHN |
Patheon NV |
EVP and CFO |
• – – |
2016-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
196,485 |
196,485 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2011-03-16 |
4 |
S |
$3.39 |
$76,725 |
D/D |
(22,615) |
57,102 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2011-03-16 |
4 |
OE |
$1.20 |
$78,000 |
D/D |
65,000 |
63,102 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-08-04 |
4 |
OE |
$1.20 |
$3,000 |
D/D |
2,500 |
14,217 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-08-04 |
4 |
AS |
$6.20 |
$15,500 |
D/D |
(2,500) |
11,717 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-06-03 |
4 |
AS |
$6.97 |
$8,713 |
D/D |
(1,250) |
11,717 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-06-03 |
4 |
OE |
$1.20 |
$1,500 |
D/D |
1,250 |
12,967 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-05-03 |
4 |
AS |
$7.68 |
$9,600 |
D/D |
(1,250) |
11,717 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-05-03 |
4 |
OE |
$1.20 |
$1,500 |
D/D |
1,250 |
12,967 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-29 |
4 |
AS |
$8.31 |
$307,387 |
D/D |
(36,990) |
9,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-29 |
4 |
OE |
$3.26 |
$120,587 |
D/D |
36,990 |
45,990 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-28 |
4 |
AS |
$8.26 |
$12,910 |
D/D |
(1,563) |
9,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-28 |
4 |
OE |
$3.26 |
$5,095 |
D/D |
1,563 |
10,563 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-12 |
4 |
AS |
$8.26 |
$4,204 |
D/D |
(509) |
11,717 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-12 |
4 |
OE |
$3.26 |
$1,659 |
D/D |
509 |
12,226 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-05 |
4 |
AS |
$6.96 |
$8,693 |
D/D |
(1,249) |
11,717 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-04-05 |
4 |
OE |
$1.20 |
$1,499 |
D/D |
1,249 |
12,966 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-03-03 |
4 |
OE |
$1.20 |
$18,000 |
D/D |
15,000 |
24,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-03-03 |
4 |
AS |
$6.96 |
$104,370 |
D/D |
(15,000) |
9,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2010-01-22 |
4 |
AS |
$7.02 |
$119,530 |
D/D |
(17,027) |
9,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2009-12-31 |
4 |
D |
$6.46 |
$50,466 |
D/D |
(7,812) |
26,027 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2009-01-30 |
4 |
B |
$1.62 |
$4,845 |
D/D |
3,000 |
6,000 |
2.66 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
SR VP & CFO |
• – – |
2008-08-04 |
4 |
B |
$2.82 |
$8,466 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
